Proresorptive actions of FSH and bone loss

Annals of the New York Academy of Sciences

Volumn 1116, Issue , 2007, Pages 376-382

  Zaidi, Mone ^a   Blair, Harry C ^b   Iqbal, Jameel ^a   Zhu, Ling Ling ^a   Kumar, T Rajendra ^c   Zallone, Alberta ^d   Sun, Li ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BARI   (Italy)

Author keywords

Hypogonadism; Osteoclast; Osteoporosis

Indexed keywords

ESTROGEN; FOLLITROPIN;

CLIMACTERIUM; CONFERENCE PAPER; GONADAL DISEASE; HUMAN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PERFORATION; PHYSIOLOGY; TRABECULAR BONE;

EID: 37249090677     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.056     Document Type: Conference Paper

References (25)

1. ALBRIGHT, F., P.H. SMITH & A.M. RICHARDSON. 1941. Post menopausal osteoporosis. JAMA 1167: 2465-2474.
2. RIGGS, B.L., S. KHOSLA, L.J. MELTON III. 2002. Sex steroids and the construction and conservation of the adult skeleton. Endoc. Rev. 23: 279-302.
3. SHEVDE, N.K., A.C. BENDIXEN, K.M. DIENGER & J.W. PIKE. 2000. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-jun repression. Proc. Natl. Acad. Sci. 97: 7829-7834.
4. SRIVASTAVA, S., G. TORALDO, M.N. WEITZMANN, et al. 2002. Estrogen decreases osteoclast formation by downregulating receptor activator for NF-kappa B ligand induced JNK activation. J. Biol. Chem. 276: 8836-8840.
5. SRIVASTAVA, S., M.N. WEITZMANN, R.B. KIMBLE, et al. 1998. Estrogen blocks MCSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J. Clin. Invest. 102: 1850-1859.
6. ROGGIA, C., Y. GAO, S. CENCI, et al. 2001. Up-regulation of TNF producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc. Natl. Acad. Sci. 98: 13960-13965.
7. GARCÍA PALACIOS, V., L.J. ROBINSON, C.W. BORYSENKO, et al. 2005. Negative regulation of RANKL induced osteoclastic differentiation in RAW264.7 cells by estrogen and phytoestrogens. J. Biol. Chem. 280: 13720-13727.
8. ARMOUR, K.E., K.J. ARMOUR, M.E. GALLAGHER, et al. 2001. Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitrix oxide synthase. Endocrinology 142: 760-766.
9. JAGGER, C.J., J.W. CHOW & T.J. CHAMBERS. 1996. Estrogen suppresses activation but enhances formation phase of osteogenic response to mechanical stimulation in rat bone. J. Clin. Invest. 98: 2351-2357.
10. RANDOLPH, J.F., M. SOWERS, I.V. BONDARENKO, et al. 2004. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J. Clin. Endocrinol. Metabol. 89: 1555-1561.
11. AKHTER, M.P., J.M. LAPPE, K.M. DAVIES & R.R. RECKER. 2007. Transmenopausal changes in the trabecular bone structure. Bone 41: 111-116.
12. SUN, L., Y. PENG, A.C. SHARROW, et al. 2006. FSH directly regulates bone mass. Cell 125: 247-260.
13. WU, Y., J. TORCHIA, W. YAO, et al. 2007. Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen deficiency. PLoS ONE 2: e586.
14. GAO, J., R. TIWARI-PANDEY, R. SAMADFAM, et al. 2007. Altered ovarian function affects skeletal homeostasis independent of the action of follicle stimulating hormone. Endocrinology 148: 2613-2621.
15. MIYAURA, C., K. TODA, M. INADA, et al. 2001. Sex- and age-related response to aromatase deficiency in bone. Biochem. Biophys. Res. Commun. 280: 1062-1068.
16. SIMS, N.A., S. DUPONT, A. KRUST et al. 2002. Deletion of estrogen receptors reveals a regulatory role for estrogen receptor-beta in bone remodeling in females but not in males. Bone 30: 18-25.
17. DAWSON-HUGHES, B. 2001. Bone loss accompanying medical therapies. N. Engl. J. Med. 345: 989-992.
18. SOWERS, M.R., G.A. GREENDALE, J. BONDARENKO, et al. 2003. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Ost. Internat. 14: 191-197.
19. SOWERS, M.R., M. JANNAUSCH, D. MCCONNELL, et al. 2006. Hormone predictors of bone mineral density changes during the menopausal transition. J. Clin. Endocrinol. Metabol. 91: 1261-1267.
20. DEVLETA, B., B. ADEM & S. SENEDA. 2004. Hypergonadotropic amenorrhea and bone density: new approach to an old problem. J. Bone Miner. Res. 22: 360-364.
21. GADDY-KURTEN, D., J.K. COKER, E. ABE, et al. 2002. Inhibiin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 143: 74-83.
22. EIJKEN, M., S. SWAGEMAKERS, M. KOEDAM, et al. 2007. Activin A-follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J. Epub. April 20.
23. IQBAL, J., L. SUN, T.R. KUMAR, et al. 2006. Follicle stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc. Natl. Acad. Sci. 103: 14925-14930.
24. BRITT, K.L., A.E. DRUMMOND, M. DYSON, et al. 2001. The ovarian phenotype of the aromatase knockout (ArKO) mouse. J. Steroid Biochem. Mol. Biol. 79: 181-185.
25. COUSE, J.F., M.M. YATES, V.R. WALKER, et al. 2003. Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) null mice reveals hypergonadism and endocrine sex reversal in females lacking ERalpha but not ERbeta. Mol. Endocrinol. 17: 1039-1053.